Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT PHILIP ALBARES

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1225081177
CMS profile
191830
Location
DOTHAN, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$2,087.27

99 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,087.27 99

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT PHILIP ALBARES

NPI 1225081177 · CMS profile ID 191830

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

DOTHAN, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1225081177?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT PHILIP ALBARES, NPI 1225081177, CMS profile ID 191830. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1225081177?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ROBERT PHILIP ALBARES, NPI 1225081177, CMS profile ID 191830. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1225081177?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ROBERT PHILIP ALBARES, NPI 1225081177, CMS profile ID 191830, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1225081177?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

99 matching records · $2,087.27 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 99 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–99 of 99.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
IRONWOOD PHARMACEUTICALS, INC $15.0607/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153739648 CMS
Janssen Biotech, Inc. $19.3907/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078256847 CMS
Phathom Pharmaceuticals, Inc. $18.2207/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151033510 CMS
ABBVIE INC. $15.1807/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197380 CMS
Janssen Biotech, Inc. $19.3907/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078257603 CMS
ABBVIE INC. $28.7907/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197378 CMS
ABBVIE INC. $11.2207/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197376 CMS
ABBVIE INC. $20.6207/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197374 CMS
ABBVIE INC. $2.0806/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197372 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.1406/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153435647 CMS
Braintree Laboratories, Inc. $16.9506/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125512687 CMS
Janssen Biotech, Inc. $19.8506/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078257985 CMS
Celgene Corporation $13.2906/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101122436 CMS
Janssen Biotech, Inc. $16.7506/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078257933 CMS
ABBVIE INC. $23.0306/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197370 CMS
Phathom Pharmaceuticals, Inc. $17.0506/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151033508 CMS
ABBVIE INC. $12.4406/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197368 CMS
ABBVIE INC. $22.0505/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197366 CMS
Janssen Biotech, Inc. $19.9705/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078257219 CMS
Merck Sharp & Dohme LLC $24.3005/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141684759 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.9705/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153492895 CMS
Regeneron Healthcare Solutions, Inc. $13.4205/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113996674 CMS
Janssen Biotech, Inc. $18.7705/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078257965 CMS
ABBVIE INC. $3.9504/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197360 CMS
ABBVIE INC. $15.3004/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197362 CMS
ABBVIE INC. $8.1504/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197364 CMS
Merck Sharp & Dohme LLC $21.7404/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141865493 CMS
GENZYME CORPORATION $24.1504/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139964705 CMS
IRONWOOD PHARMACEUTICALS, INC $20.0104/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153722266 CMS
ABBVIE INC. $17.7204/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197358 CMS
ABBVIE INC. $13.7404/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197356 CMS
ABBVIE INC. $24.5503/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197354 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.7303/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153571318 CMS
Celgene Corporation $21.4603/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101122430 CMS
ABBVIE INC. $19.3203/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197350 CMS
ABBVIE INC. $19.7903/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197352 CMS
AIMMUNE THERAPEUTICS, INC. $14.1703/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147015076 CMS
AIMMUNE THERAPEUTICS, INC. $15.9003/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147015116 CMS
Phathom Pharmaceuticals, Inc. $17.3103/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151033506 CMS
ABBVIE INC. $11.8903/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197348 CMS
Intercept Pharmaceuticals, Inc. $18.5102/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113641539 CMS
ABBVIE INC. $19.0402/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197346 CMS
Medtronic, Inc. $17.1202/06/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247173085 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.8702/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137466565 CMS
AIMMUNE THERAPEUTICS, INC. $14.4101/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147021659 CMS
ABBVIE INC. $10.6201/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197344 CMS
Janssen Biotech, Inc. $18.9301/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078257447 CMS
Lilly USA, LLC $15.8301/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135398083 CMS
ABBVIE INC. $12.5001/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103197342 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $807.13 54
PY2020 $675.97 56
PY2021 $1,268.99 65
PY2022 $1,090.88 70
PY2023 $853.36 56
PY2024 $2,087.27 99
PY2025 $2,477.63 123

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $8,400.60 11
PY2020 Principal investigator $27,495.73 35
PY2019 Principal investigator $51,820.89 31

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $179.50 02/19/2021 Non-covered Recipient Entity
TARHEEL CLINICAL RESEARCH LLC
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789012951
Principal investigator 1 Allergan, Inc. $347.50 02/19/2021 Non-covered Recipient Entity
TARHEEL CLINICAL RESEARCH LLC
46 weeks, placebo controlled (pts from 01/02 studies roll over for 53 weeks total exposure) No dispute reported 06/30/2026 789012953
Principal investigator 1 Allergan, Inc. $1,800.00 02/16/2021 Non-covered Recipient Entity
DIGESTIVE HEALTH SPECIALISTS OF THE SOUTHEAST (DB
Open-label Extension Study of Relamorelin for the treatment of diabetic gastroparesis (DG) No dispute reported 06/30/2026 789012941
Principal investigator 1 Allergan, Inc. $200.00 02/16/2021 Non-covered Recipient Entity
DIGESTIVE HEALTH SPECIALISTS OF THE SOUTHEAST (DB
Open-label Extension Study of Relamorelin for the treatment of diabetic gastroparesis (DG) No dispute reported 06/30/2026 789012943
Principal investigator 1 Allergan, Inc. $1,500.00 02/16/2021 Non-covered Recipient Entity
DIGESTIVE HEALTH SPECIALISTS OF THE SOUTHEAST (DB
Open-label Extension Study of Relamorelin for the treatment of diabetic gastroparesis (DG) No dispute reported 06/30/2026 789012945
Principal investigator 1 Allergan, Inc. $300.00 02/16/2021 Non-covered Recipient Entity
DIGESTIVE HEALTH SPECIALISTS OF THE SOUTHEAST (DB
Open-label Extension Study of Relamorelin for the treatment of diabetic gastroparesis (DG) No dispute reported 06/30/2026 789012947
Principal investigator 1 Allergan, Inc. $600.00 02/16/2021 Non-covered Recipient Entity
DIGESTIVE HEALTH SPECIALISTS OF THE SOUTHEAST (DB
Open-label Extension Study of Relamorelin for the treatment of diabetic gastroparesis (DG) No dispute reported 06/30/2026 789012949
Principal investigator 1 Allergan, Inc. $413.75 02/05/2021 Non-covered Recipient Entity
DIGESTIVE HEALTH SPECIALISTS OF THE SOUTHEAST (DB
Open-label Extension Study of Relamorelin for the treatment of diabetic gastroparesis (DG) No dispute reported 06/30/2026 789012939
Principal investigator 1 Allergan, Inc. $444.90 01/22/2021 Non-covered Recipient Entity
TARHEEL CLINICAL RESEARCH LLC
A 52-week, double blind, Phase 3 Study for Assessment of the Safety and Effectiveness of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789012937
Principal investigator 1 Allergan, Inc. $1,173.50 01/19/2021 Non-covered Recipient Entity
TARHEEL CLINICAL RESEARCH LLC
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789012935
Principal investigator 1 Allergan, Inc. $1,441.45 01/14/2021 Non-covered Recipient Entity
TARHEEL CLINICAL RESEARCH LLC
A 52-week, double blind, Phase 3 Study for Assessment of the Safety and Effectiveness of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789012933